Robust in-vivo expansion is the non-negotiable gatekeeper for durable CAR-T/NK efficacy, especially in hostile solid-tumor microenvironments. Creative Biolabs' CellRapeutics™ Proliferation Test Service provides comprehensive and precise kinetic profiling services for CAR-T/NK cell proliferation based on industry-leading multi-platform detection technologies and extensive experience. We deliver multi-dimensional data outcomes, including growth curves, activation status, and viability metrics, accompanied by in-depth interpretation from both functional and mechanistic perspectives, offering robust, actionable data support to facilitate your research and development process.
Within the translational trajectory of CAR-T cell therapeutics, proliferative competence constitutes a decisive surrogate of in vivo potency and persistence. In solid malignancy settings, the amplitude of post-infusion CAR-T expansion directly conditions the depth of objective response and, by extension, long-term clinical benefit. A phase I trial of GD2-directed CAR-T cells in osteosarcoma and neuroblastoma, interrogated by multi-omics profiling, demonstrated that the pre-treatment frequency of CXCR3⁺ monocytes and the baseline reservoir of naive T cells jointly predict the magnitude of CAR-T expansion. Consequently, rigorous, prospective quantification of proliferative potential is imperative to inform rational vector engineering, manufacturing optimization, and combinatorial treatment algorithms.
Fig.1 Immune signatures dictating CAR-T expansion in GD2-targeted solid tumor therapy.
Creative Biolabs' CellRapeutics™ Proliferation Test Service provides a comprehensive service to accurately and quantitatively measure this key parameter. Our deliverables include not just raw data, but a full analysis and interpretation of cell growth, activation, and viability. We help you understand the dynamics of your therapeutic cells, providing the critical insights needed to advance your project from the lab bench to clinical application.
We offer comprehensive and customized proliferation assay services, enabling precise evaluation of cellular expansion kinetics to support your research and development. Additionally, we offer cytokine concentration profiling to assess secretory biomarkers associated with immune cell activation and proliferation, further strengthening the mechanistic insight into cell performance.
Required Starting Materials: At the project initiation stage, it is typically necessary for you to provide engineered CAR-T cell samples, as well as relevant target cancer cell lines for co-culture experiments. Furthermore, well-defined research objectives, such as specific cytokines to be measured or desired proliferation markers, are essential for developing a highly tailored experimental design.
Key Steps Involved:
Final Deliverables:
How do you handle my samples to ensure viability and data integrity?
We adhere to stringent and validated standard operating procedures for the receipt, handling, and culture of all cell samples. Upon arrival, each sample undergoes rigorous quality control checks by our dedicated team of experts. Furthermore, all samples are systematically tracked throughout every stage of the process to guarantee data integrity and reproducibility.
Can you help me choose the right proliferation assay for my specific project?
Of course. Integral to our service offering is an initial consultation, during which our scientific team will engage in a detailed discussion regarding your research objectives, available resources, and expected outcomes. Based on this assessment, we will recommend the most appropriate assays from our extensive selection.
Creative Biolabs distinguishes itself through profound expertise in adoptive cell therapy development and a dedicated commitment to delivering a comprehensive "one-stop" solution to meet all your research requirements. Leveraging proprietary protocols and advanced technologies, we ensure rapid turnaround times while maintaining uncompromised data quality and reliability. Our services are built upon decades of consolidated experience and are supported by robust, published data that validates the efficacy of our methodologies.
"The ability to choose from a variety of assays, from colorimetric methods like CCK8 to cell tracing with CFSE, was invaluable. The Creative Biolabs team provided consistent and high-quality data across different methods, which greatly strengthened the conclusions of our latest publication." L* K**.
"Using Creative Biolabs' CellRapeutics™ Proliferation Test Service in our research has significantly facilitated the parametrization of our kinetic models for CAR T-cell dynamics. The precise, real-time data we received allowed us to accurately model T-cell exhaustion and killing rates, which was crucial for optimizing our therapeutic strategy." J* M**.
" The expert analysis and interpretation provided by the Creative Biolabs team were a huge advantage. They didn't just provide raw data; they helped us understand the implications of our results in the context of our specific project goals." S* P**.
Our CellRapeutics™ Proliferation Test Service is an integral element of our end-to-end support for adoptive cell therapy development. We deliver robust data and specialized perspectives designed to advance your research programs.
To learn more or explore collaboration opportunities, please reach out to our team for a detailed consultation.
Partner with Creative Biolabs for Tailored Solutions — Inquire Now
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION